Over the past three days of the ๐๐๐ฅ๐@๐ฒ๐ฌ Conference in Lyon, discussions highlighted how central highโquality cancer data are to โ๐ฉ๐ช๐ง๐ฃ๐๐ฃ๐ ๐๐๐ฃ๐๐๐ง ๐ง๐๐จ๐๐๐ง๐๐ ๐๐ฃ๐ฉ๐ค ๐๐๐ฉ๐๐ค๐ฃโ. From discovery and innovation, to implementation, to the scienceโpolicy interface and evidenceโbased policyโmaking grounded in independent science.
In this context, the CancerWatch JA poster โ๐๐ค๐ฅ๐ช๐ก๐๐ฉ๐๐ค๐ฃ-๐ฝ๐๐จ๐๐ ๐พ๐๐ฃ๐๐๐ง ๐๐๐๐๐จ๐ฉ๐ง๐๐๐จ ๐๐ง๐ ๐ฉ๐๐ ๐๐๐ก๐ก๐๐ง๐จ ๐ค๐ ๐พ๐๐ฃ๐๐๐ง ๐พ๐ค๐ฃ๐ฉ๐ง๐ค๐ก ๐๐ฃ ๐๐ช๐ง๐ค๐ฅ๐: ๐๐ฃ๐จ๐ช๐ง๐๐ฃ๐ ๐๐ช๐จ๐ฉ๐๐๐ฃ๐๐๐๐ก๐๐ฉ๐ฎ ๐๐ฃ ๐ ๐พ๐๐๐ฃ๐๐๐ฃ๐ ๐ฟ๐๐ฉ๐ ๐๐๐ฃ๐๐จ๐๐๐ฅ๐โ was presented by Dafina Petrova, Max X., Yasmin Cura, Daniela Coza, Carmen Ungurean, Vesna Zadnik, Elizabeth Van Eycken, Gijs Geleijnse, Giske Ursin, Maria Jose Sanchez Perez, and Claudine Backes.
The work highlights that:
These preliminary findings reinforce the central role of populationโbased cancer registries in providing reliable, timely and comparable data to inform independent, evidenceโbased policies and to document and address inequalities in cancer burden and outcomes across Europe.
